ArticleFrontiers in immunology2022

Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.

Lan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.